Bristol Myers Squibb

EMPLICITI

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Bristol Myers Squibb

Empliciti HCPCS:

J9176

HCPCS Code Descriptor:

Injection, elotuzumab, 1 mg

Category:

J Code

Empliciti NDCs:

00003-4522-11, 00003-2291-11

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Empliciti CPT Codes:

-96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

-96415 - Each additional hour. List separately in addition to code for primary procedure. Use 96415 in conjunction with 96413. Report 96415 for infusion intervals of greater than 30 minutes beyond 1-hour increments

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Empliciti:

EMPLICITI is an Oncology drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J9176 is aligned to the drug EMPLICITI.

ACCESS PRICING AND MORE BY REGISTERING

J9176 Added Date:

January 1, 2017

J9176 Effective Date:

January 1, 2017

J9176 Termination Date:

HCPCS Active

Empliciti billing and coding information can be found through Bristol Myers Squibb at the link below:
Empliciti patient assistance information can be found through Bristol Myers Squibb Access Support at the URL: https://www.bmsaccesssupport.bmscustomerconnect.com/patient
EMPLICITI prescribing information can be found at the link below:
Information regarding EMPLICITI’s side effects can be found at MedlinePlus